We are live on ! Find out more
ANAC

ANACOR PHARMACEUTICALS INC COM
ANAC

Delisted

ANAC was delisted on the 23rd of June, 2016.

Back to rankings

78 hedge funds and large institutions have $321M invested in ANACOR PHARMACEUTICALS INC COM in 2013 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 31 increasing their positions, 15 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 8

107% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 15

95% more capital invested

Capital invested by funds: $165M → $321M (+$157M)

16% more funds holding

Funds holding: 67 → 78 (+11)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
78
Holders Change
+11
Holders Change %
+16.42%
% of All Funds
2.53%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
19
Increased
31
Reduced
15
Closed
8
Calls
$484K
Puts
–
Net Calls
+$484K
Net Calls Change
+$505K

Top Buyers

1
CCM
Consonance Capital Management
New York
+$6.45M
2
PA
Perceptive Advisors
New York
+$3.42M
3
SCA
SAC Capital Advisors
Connecticut
+$2.17M
4
EI
EAM Investors
California
+$1.81M
5
RFC
Russell Frank Company
Washington
+$1.35M

Top Sellers

1
CCI
Columbus Circle Investors
-$3.82M
2
PWPCM
Perella Weinberg Partners Capital Management
New York
-$2.57M
3
KCM
Kingdon Capital Management
New York
-$2.23M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$1.92M
5
LOAMU
Lombard Odier Asset Management (USA)
New York
-$1.88M
Name Holding Trade Value Shares
Change 		Change in
Stake
RCP
1
Rho Capital Partners
New York
$59.7M – – –
Wellington Management Group
2
Wellington Management Group
Massachusetts
$53.6M -$1.92M -219,154 -4%
BC
3
Broadfin Capital
New York
$18.5M +$119K +13,641 +0.8%
KCM
4
Kingdon Capital Management
New York
$18.1M -$2.23M -255,000 -13%
LOAMU
5
Lombard Odier Asset Management (USA)
New York
$18.1M -$1.88M -215,000 -11%
VM
6
VHCP Management
New York
$17.1M – – –
PAI
7
Palo Alto Investors
California
$17M -$153K -17,473 -1%
QF
8
QVT Financial
New York
$14.4M – – –
BFA
9
BlackRock Fund Advisors
California
$12.3M +$1.33M +151,601 +15%
PA
10
Perceptive Advisors
New York
$10.3M +$3.42M +391,033 +67%
BBA
11
Baker Bros. Advisors
New York
$9.31M – – –
CCM
12
Consonance Capital Management
New York
$7.83M +$6.45M +737,685 New
Vanguard Group
13
Vanguard Group
Pennsylvania
$7.44M +$18K +2,057 +0.3%
IMOV
14
Investment Management of Virginia
Virginia
$5.52M +$45.5K +5,200 +1%
FCM
15
Farallon Capital Management
California
$4.78M -$1.64M -187,500 -29%
Northern Trust
16
Northern Trust
Illinois
$3.79M +$737K +84,277 +31%
State Street
17
State Street
Massachusetts
$3.49M +$961K +109,881 +50%
BIT
18
BlackRock Institutional Trust
California
$3.24M -$193K -22,020 -7%
SCA
19
SAC Capital Advisors
Connecticut
$2.64M +$2.17M +248,478 New
EI
20
EAM Investors
California
$2.2M +$1.81M +206,933 New
BCM
21
Bridgeway Capital Management
Texas
$2.16M +$156K +17,800 +10%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$2.06M +$674K +77,069 +66%
Deutsche Bank
23
Deutsche Bank
Germany
$2.03M +$1.04M +118,671 +164%
RFC
24
Russell Frank Company
Washington
$1.63M +$1.35M +153,779 +146,456%
Invesco
25
Invesco
Georgia
$1.46M +$1.2M +137,630 New
1
2 3 4

ANAC Hedge Fund Activity: Q3 2013 in Review

78 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in ANACOR PHARMACEUTICALS INC COM (ANAC) for Q3 2013, worth a combined $321M — up 95% from $165M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new ANAC positions and 8 closed out — a net gain of 11 holders — while 31 added to existing stakes and 15 trimmed.

The largest buyer was Consonance Capital Management, opening a new position worth an estimated $6.45M. The largest seller was Columbus Circle Investors, cutting an estimated $3.82M.

  • 78 institutional investors held ANACOR PHARMACEUTICALS INC COM (ANAC) as of Q3 2013, up from 67 in Q2 2013.
  • Funds reported $321M of ANACOR PHARMACEUTICALS INC COM stock for Q3 2013, up 95% quarter-over-quarter.
  • 19 funds opened new ANACOR PHARMACEUTICALS INC COM positions in Q3 2013 and 8 closed out, a net change of +11 holders.
  • The largest ANACOR PHARMACEUTICALS INC COM buyer in Q3 2013 was Consonance Capital Management, an estimated $6.45M added.
  • The largest ANACOR PHARMACEUTICALS INC COM seller in Q3 2013 was Columbus Circle Investors, an estimated $3.82M sold.

Based on aggregated 13F filings for Q3 2013.